AdventHealthMD
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
Greg Warmoth, long-time WFTV anchor, shares his journey with lip cancer — a tale of caution and hope — in this episode of AdventHealth’s Inspiring Wholeness podcast.
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.